UroGen Pharma
URGN
#5323
Rank
A$2.33 B
Marketcap
A$47.67
Share price
6.51%
Change (1 day)
22.43%
Change (1 year)

EPS for UroGen Pharma (URGN)

EPS in 2026 (TTM): A-$1.93

According to UroGen Pharma's latest financial reports the company's current EPS (TTM) is A-$1.98. In 2025 the company made an earnings per share (EPS) of A-$4.81 a decrease over its 2024 EPS that were of A-$4.51.

EPS history for UroGen Pharma from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.93-59.78%
2025A-$4.816.67%
2024A-$4.51
2022A-$7.18-3.63%
2021A-$7.45-16.22%
2020A-$8.89
2018A-$7.15160.58%
2017A-$2.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.03 2.27%๐Ÿ‡บ๐Ÿ‡ธ USA